Neurology Central

Recurrent glioblastoma could be effectively treated using pembrolizumab

Robert Prins and Timothy Cloughesy, lead authors from University of California (CA, USA) and colleagues have shown for the first time that pembrolizumab can be effective in treating people with recurrent glioblastoma.

In the study, people treated with pembrolizumab before surgery lived almost twice as long as the average life expectancy for people with the disease. The study was recently published in Nature Medicine.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.